Cannabis Observations on Brain Waves, Retrieval, and Attention: Experiment 4
L. Cinnamon Bidwell · with National Institute on Drug Abuse (NIDA) · NCT07679581
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 21–40 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 64
- US sites recruiting
- 1
- Study start
- December 10, 2025
- Record last updated
- July 1, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
This study investigates the impact of ∆9-tetrahydrocannabinol (THC) and cannabidiol (CBD) on recognition memory in healthy, regular cannabis users. Participants complete the same recognition memory task after self-administering one of two different strains of cannabis flower one day and while not intoxicated another day. Event-related potentials (ERPs) are measured via electroencephalogram (EEG) during the recognition memory task. Blood is collected to quantify THC and CBD exposure. Participants also complete self-report measures of medical history, sleep quality, subjective cognitive function, physical activity, psychological functioning, substance use, and acute drug effects.
Being studied: Cannabis (smoked flower)
Conditions: Cannabis; Memory; Electroencephalography
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
- Must be between the ages of 21 and 40 and provide informed consent;
- Must be right-handed (Laterality Quotient > 60 on Edinburgh Handedness Inventory - Short Form136);
- Heavy users (HU) in Experiments 1, 2, 3, and 4:
- Must use cannabis at least 4 days during the month;
- Must be a cannabis user for at least a year;
- Non-users (NU) in Experiment 2:
- Must not have used cannabis for prior 6 months;
- Must have at least one episode of lifetime cannabis use;
- Must self-report not using other illicit recreational drugs (e.g., cocaine, benzodiazepines (non-prescription), opiates (non-prescription), MDMA, sedatives, or methamphetamine) in the past 30 days, during the Pre-Screening;
- Must not test positive on a urine toxicology test for drugs of abuse at the Baseline Appointment (TDS);
- Must not be using psychotropic medications, however anti-depressant, non-benzodiazepine anti-anxiety, and ADHD medications are ok. ADHD medication users must be willing to abstain from ADHD medication use on appointment days; ADHD medications, even extended-release forms, are short acting and medication" holidays" (e.g., on weekends and holidays) are routine in individuals prescribed ADHD medications, without adverse effects.
- Must not be a regular nicotine user (≤4 days per week; cigarette, E-cigs, or smokeless);
- Must not have used caffeine or nicotine (cigarette, E-cigs, or smokeless) for 4 hours;
- Must have a breath alcohol level of 0 at screening (to sign consent form);
- Must not be actively seeking or in treatment for any substance use disorder (drug use levels will be carefully monitored via Timeline Follow Back (TLFB) throughout the study to assess any confounding influences of drug or alcohol use;
- Female subjects must not be or trying to become pregnant (as indicated by a pregnancy test \& screening form administered at Baseline);
- Must not be in treatment for psychotic disorder or bipolar disorder; or have a history with these disorders;
- Must not have any physical characteristics (e.g., thick hair, head size exceeding the limit of the net, dyed hair) or experience any technical difficulties during testing that result in a poor-quality EEG recording.
- Participants in Experiment 4 a. Must not have participated in Experiment 3
Recruiting US locations
Center for Innovation and Creativity (CINC)
Boulder, CO 80301
Site contact: Katie N Paulich, Ph.D. · 303-492-9549 · cobra.custudy@gmail.com
Study contacts (from the official record)
- Katie N Paulich, Ph.D. · 303-492-9549 · cobra.custudy@gmail.com
Similar studies in Colorado
All healthy volunteers studies in Colorado →- RecruitingHealthy volunteersPhase 1/Phase 2
A Study of BLB-201 RSV Vaccine in Infants and Children
Blue Lake Biotechnology Inc.
- Location
- Aurora, CO + 13 other US sites
- Eligibility basics
- Ages 6 mo–5
- RecruitingHealthy volunteersPhase 1
Study to Evaluate the Safety, Pharmacokinetic, and Pharmacodynamic Effects of MY006 in Healthy Volunteers and Patients With Peanut Allergy
Mabylon AG
- Location
- Aurora, CO + 7 other US sites
- Eligibility basics
- Ages 12–55
- RecruitingHealthy volunteersPhase 1
A Research Study Looking at How Different Doses of Study Medicine (Inno8) Work in the Body of People With Haemophilia A
Novo Nordisk A/S
- Location
- Aurora, CO + 4 other US sites
- Eligibility basics
- Ages 18–64 · Men only
- RecruitingHealthy volunteersPhase 1/Phase 2
A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)
Novartis Pharmaceuticals
- Location
- Aurora, CO + 18 other US sites
- Eligibility basics
- Ages 18–100